A federal “right-to-try” law for medical treatments could soon become reality. But systems to expand access to investigational options while protecting patients are already in place, says a U-M expert.
As Research & Policy Media Relations Manager at the U-M Institute for Healthcare Policy and Innovation (IHPI), Kara Gavin draws on 25 years of experience in communicating about science, medicine and health policy. Her responsibilities include creating compelling stories about discoveries made by the U-M Medical School's biomedical and mental health researchers, the findings and opinions of the 490 healthcare wonks at the U-M IHPI, and the innovative education available at U-M for future doctors and medical scientists.
New U-M research has shown that pluripotent stem cells can self-organize into a structure similar to the amniotic sac, an early stage of human development. The discovery could be used to study why pregnancies fail.
A new discovery expands researchers’ understanding of bone marrow’s role in HIV, potentially leading to treatments that could rid patients of the infection for life.
A study of DNA from prehistoric German dogs yielded new clues about how dogs became domesticated from wolves. The same techniques can teach us about our own ancient origins — and diseases that affect both species.
As more Americans turn to bariatric surgery for weight loss, a new study suggests they may not want to wait until their BMI exceeds 40 to reap the biggest benefits.
Prescription drug monitoring programs could help fight a national epidemic and boost the effort to get people treatment, research shows. But states differ widely in implementation.